Medicare claims for genetic cancer tests face growing rejection rates
The Evolving Landscape of Next-Generation Sequencing (NGS) in Cancer Care Recent Trends and Challenges Between 2016 and 2021, the adoption of advanced genetic testing like next-generation sequencing (NGS) in cancer care has seen notable increases. However, this rise has paralleled a concerning trend: heightened rates of claim denials post-testing. Researchers at Georgetown University, in collaboration … Read more